Get started
Author

Anna Sanders

Observed name: A Sanders
ORCID: 0000-0002-8237-9039
Observed ORCID: 0000-0002-8237-9039
OpenAlex ID: A5047572581
The diagnosis and management of subclinical hypothyroidism is assay‐dependent– Implications for clinical practice
2021 · Tejas Kalaria, Anna Sanders, et al. · Clinical Endocrinology · 20
Biotin immunoassay interference: A UK-based prevalence study
2020 · A Sanders, R Gama, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 14
The Diagnosis of Normocalcaemic Hyperparathyroidism is Strikingly Dissimilar Using Different Commercial Laboratory Assays
2022 · Tejas Kalaria, Jonathan Fenn, et al. · Hormone and Metabolic Research · 11
PDF
Environmental sustainability of clinical laboratories: A scoping review
2025 · RJ Shorten, A Sanders, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 8
PDF
Biochemical assessment of adequate levothyroxine replacement in primary hypothyroidism differs with different TSH assays: potential clinical implications
2021 · Tejas R Kalaria, Anna Sanders, et al. · Journal of Clinical Pathology · 8
Clinical concordance assessment should be an integral component of laboratory method comparison studies: A regression transference of routine clinical data approach
2022 · Tejas Kalaria, Jonathan Fenn, et al. · Clinical Biochemistry · 7
Analytical method comparisons do not consider the comparison of reference ranges which may lead to differences in diagnosis and patient management: A case for clinical discordance checks
2021 · Tejas Kalaria, Anna Sanders, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 3
Different thyroid assays may greatly affect diagnosis and management of hypothyroidism
2021 · Tejas Kalaria, Anna Sanders, et al. · BMJ · 2
The Application of Assay- and Age-Specific Parathyroid Hormone (PTH) Reference Intervals Decreases the Diagnosis of Normocalcaemic Primary Hyperparathyroidism and Improves Diagnostic Concordance of PTH Assays
2025 · Halimah Khalil, Jonathan Fenn, et al. · Hormone and Metabolic Research · 1
Normocalcaemic hyperparathyroidism: Impact of assay and reference range differences on the diagnosis
2021 · Jonathan Fenn, Tejas Kalaria, et al. · Endocrine Abstracts · 1
Samples spiked with pituitary-derived thyroid-stimulating hormone may disguise the extent of differences between thyroid-stimulating hormone assays
2021 · Tejas Kalaria, Jonathan Fenn, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 1
The diagnostic incidence of normocalcaemic hyperparathyroidism decreases and diagnostic concordance of parathyroid hormone (PTH) assays improves with assay- and age-specific PTH reference intervals
2025 · Halimah Khalil, Anna Sanders, et al. · Endocrine Abstracts
The pragmatic use of corticosteroids in the diagnosis and treatment of non-PTH driven hypercalcaemia
2021 · Yasear Zainab Akram Yousif, Nadia Ijaz, et al. · Endocrine Abstracts
Works count: 13
Citation count: 76
H-index: 6
I10-index: 3
Year
Topic
Type